What is Acadia?
Acadia NeuroRehab is a specialized provider of comprehensive neuro-rehabilitation services, catering to individuals recovering from traumatic brain injuries and other neurological conditions. With over three and a half decades of operational experience, the organization offers flexible, person-centered programs across residential, outpatient, and community-based settings. Their multidisciplinary team delivers tailored therapies, including physical, occupational, speech, and cognitive rehabilitation, aimed at enhancing client autonomy and overall well-being. Operating primarily in Pennsylvania and New Jersey, Acadia NeuroRehab is dedicated to empowering its clients to achieve their highest potential and improve their quality of life.
How much funding has Acadia raised?
Acadia has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Acadia?
The substantial capital infusion, particularly the recent strategic investment, positions Acadia for accelerated expansion and enhanced service delivery. As a company operating within the late-stage funding environment, this backing is likely to fuel advancements in their therapeutic methodologies, potential geographic expansion, and the integration of innovative technologies to further support individuals with neurological challenges. The focus on autonomy and well-being suggests a strategic direction towards deepening their impact within existing markets and potentially exploring new avenues for specialized care.
See full Acadia company page
